7. Simpozijum o kortikalnim bolestima

Menu

Symposium Program

FRIDAY, May 29, 2026
SESSION 1
  1. Tuberous Sclerosis Complex – Diagnostic and Therapeutic Continuum 
    Jasna Jančić, Faculty of Medicine, University of Belgrade, Clinic for Neurology and Psychiatry for Children and Adolescents, Belgrade

  2. Treatment of Epilepsy in Patients with Tuberous Sclerosis Complex
    Galina Stevanović, Clinic for Neurology and Psychiatry for Children and Adolescents, Belgrade

  3. Pain and Headaches in Neurocutaneous Disorders
    Milija Mijajlović, Faculty of Medicine, University of Belgrade, Clinic for Neurology, University Clinical Center of Serbia

  4. Neuro-ophthalmological Manifestations of Neurocutaneous Disorders
    Jovana Vukadinović, Clinic for Neurology and Psychiatry for Children and Adolescents, Belgrade

OPENING OF THE CONFERENCE

Prof. Dr. Aleksandar Ristić – President of the Neurological Society of Serbia
Prof. Dr. Slobodan Vojinović – Director of the Clinic for Neurology, University Clinical Center Niš

SESSION 2

  1. Epilepsy Research Highlights in 2025: Key Advances and Emergency Directions
    Stevo Lukić, Faculty of Medicine, University of Niš, Clinic for Neurology, University Clinical Center Niš, Niš, Serbia

  2. Post-Stroke Cognitive Impairment (PSCI) – Update
    Natan Bornstein, Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel

  3. TBA
    Slobodan Vojinović, Faculty of Medicine, University of Belgrade, Clinic for Neurology, University Clinical Center Niš, Niš, Serbia

SATURDAY, May 30, 2026
SESSION 3
  1. Amyloid-Targeting Therapies in Practice – Real-Life Experiences in Patient Selection and Management at Tel-Aviv Medical Center
    Noa Bregman, Center for Memory and Attention Disorders, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  2. Targeting Amyloid Pathology in Alzheimer’s Disease: Comparison of EMA-Approved Drugs
    Marina Boban, Department of Cognitive Neurology, Referral Center for Cognitive Neurology and Neurophysiology (Croatian Ministry of Health), University Hospital Centre Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia
  3. From Research to Reality: Readiness of Memory Clinics for Disease-Modifying Alzheimer’s Treatment
    Milica Kramberger, Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
SESSION 4
  1. Contemporary Approach to the Treatment of Low-Grade Epilepsy-Associated Tumors (LEAT)
    Aleksandar Ristić, Faculty of Medicine, University of Belgrade, Clinic for Neurology, University Clinical Center of Serbia, Belgrade, Serbia
  2. Clinical Experience with Stereotactic EEG and Thermocoagulation in the Surgical Management of Focal Epilepsies
    Anna Kelemen, National Institute of Neurosciences, Epilepsy Center, Head of EMU, Budapest, Hungary
  3. TBA
    Ana Doneva, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Clinic for Neurology, Skopje, North Macedonia
  4. Sleep, Dream Physiology and Insomnia
    Nikola Vojvodić, Faculty of Medicine, University of Belgrade, Clinic for Neurology, University Clinical Center of Serbia, Belgrade, Serbia
SESSION 5
  1. Alzheimer’s disease before dementia: early diagnosis and implications for disease-modifying therapy
    Vuk Milošević, Clinic of Neurology, University Clinical Center Niš, Niš, Serbia; Faculty of Medicine, University of Niš, Niš, Serbia
  2. Plasma Biomarkers in Alzheimer’s Disease: Implications for Early Diagnosis and Patient Selection for Anti-Amyloid Therapy
    Gorana Mandić    , Clinic of Neurology, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  3. The Role of ApoE Genotype in Patient Selection, Therapeutic Response, and ARIA Risk During Anti-Amyloid Therapy
    Smiljana Kostić    , Clinic of Neurology, Military Medical Academy, Belgrade, Serbia
  4. Biomarkers and Clinicopathological Heterogeneity in Understanding the Therapeutic Response to Anti-Amyloid Antibodies in Alzheimer’s Disease
    Marija Semnic    , Clinic of Neurology, University Clinical Center of Vojvodina, Novi Sad, Serbia;
    Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
SESSION 6
  1. Characteristics of Interictal Epileptiform Patterns
    Boban Biševac, Clinic for Neurology, University Clinical Center Niš, Faculty of Medicine, University of Niš, Niš, Serbia
  2. Ictal Epileptiform Patterns
    Maja Milovanović, Institute of Mental Health, Belgrade, Faculty of Special Education and Rehabilitation, University of Belgrade, Belgrade, Serbia
  3. Invasive EEG in the Presurgical Evaluation of Epilepsy
    Aleksandar Ristić, Faculty of Medicine, University of Belgrade, Clinic for Neurology, University Clinical Center of Serbia, Belgrade, Serbia
  4. Periodic Discharges: An EEG Pattern Requiring Therapeutic Decision-Making
    Vladimir Galić, Clinic for Neurology, University Clinical Center of Vojvodina, Novi Sad, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
SUNDAY, May 31, 2025
SESSION 7
  1. Cognitive Reserve, Aβ Biomarkers and MRI Imaging in Alzheimer’s Disease: A Potential Framework for Understanding Therapeutic Response
    Tanja Stojković, Clinic for Neurology, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  2. Is Concomitant Cerebral Amyloid Angiopathy (CAA) the Main Risk Factor for the Development of ARIA
    Tijana Vujanić Stankov, Clinic for Neurology, University Clinical Center of Vojvodina, Novi Sad, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  3. Potential Role of Low-Field MRI in Monitoring ARIA During Anti-Amyloid Therapy in Alzheimer’s Disease
    Irena Živković, MRI Hardware Development Laboratory, Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
SESSION 8
  1. MRI in the Era of Anti-Amyloid Therapy: The Role of the Radiologist in Patient Selection and Safety Monitoring
    Aleksandra Trenkić Aracki, Center for Radiology, University Clinical Center Niš, Faculty of Medicine, University of Niš, Niš, Serbia
  2. Imaging in Patients with Seizures
    Vesna Stokanović, Center for Radiology, University Clinical Center Niš, Niš, Serbia
  3. Neuroradiology from a Neurologist’s Perspective
    Nikola Ivančević, Faculty of Medicine, University of Belgrade, Clinic for Neurology and Psychiatry for Children and Adolescents, Belgrade, Serbia

SIMPOZIJUM O KORTIKALNIM BOLESTIMA

 

KOTIZACIJA:
(u dinarskoj protivrednosti)

  • Lekari specijalisti – 200EUR
  • Lekari na specijalizaciji i ostali učesnici – 100EUR

 

Kotizacija uključuje:

  • Pristup svim naučnim sesijama Simpozijuma
  • Štampani materijal Simpozijuma
  • Pristup izložbenom prostoru
  • Osveženje tokom pauza predviđenih programom
  • Prisustvo svečanoj večeri 24. 05.

 

SMEŠTAJ (pun pansion 23.05. – 25.05.)
(u dinarskoj protivrednosti)

  • jednokrevetna soba – 250EUR
  • dvokrevetna soba – 190EUR po osobi

Sokobanja

It is located in the valley of the same name, surrounded by a range of moderately high mountains: Rtanj to the north (1560 m), Ozren to the south (1174 m), Devica to the southeast (1116 m), Slemen (1099 m) and Krstatac (1069 m) to the east, and Bukovik (894 m) and Rožanj (897 m) to the west. The Moravica River flows through Sokobanja and forms Lake Bovan on the western side of the valley. It is 230 km from Belgrade and 60 km from Niš and the Niš Airport.

Experience the Magic of Nature in Sokobanja

Tourist Organization of Sokobanja
Nature of Sokobanja
Cultural Heritage